- Written by ClinicalTrials.gov
- Category: Joint Diseases
Interventions: Drug: Tofacitinib 5 mg BID; Drug: Tofacitinib 10 mg BID; Drug: Adalimumab; Drug: Placebo; Drug: Placebo
Sponsors: Pfizer; Pfizer
Not yet recruiting - verified September 2013
- Details